• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 5. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006

Introduction to 3-bromo-6-chlorophenanthrene (CAS No. 892550-44-6)

3-bromo-6-chlorophenanthrene, identified by the Chemical Abstracts Service Number (CAS No.) 892550-44-6, is a halogenated polycyclic aromatic hydrocarbon (PAH) that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its bromine and chlorine substituents on a phenanthrene core, exhibits unique structural and electronic properties that make it a valuable intermediate in synthetic chemistry and a subject of interest for potential applications in medicinal chemistry.

The molecular structure of 3-bromo-6-chlorophenanthrene consists of a fused benzene ring system with bromine and chlorine atoms attached at the 3rd and 6th positions, respectively. This arrangement imparts distinct reactivity patterns, making it a versatile building block for the synthesis of more complex molecules. The presence of both bromine and chlorine atoms allows for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which are widely employed in the construction of biaryl compounds.

In recent years, the study of halogenated PAHs like 3-bromo-6-chlorophenanthrene has been driven by their potential applications in drug discovery and material science. PAHs, in general, are known for their role as precursors in the synthesis of various pharmacologically active compounds. The halogenation process enhances the lipophilicity and metabolic stability of these molecules, which are critical factors in drug design. Specifically, 3-bromo-6-chlorophenanthrene has been explored as a precursor in the development of novel antimicrobial agents and anticancer drugs.

One of the most compelling aspects of 3-bromo-6-chlorophenanthrene is its utility in medicinal chemistry due to its ability to serve as a scaffold for designing small-molecule inhibitors. Researchers have leveraged its structural features to develop compounds with targeted biological activity. For instance, modifications at the bromine and chlorine positions have been shown to modulate interactions with biological targets, leading to improved efficacy and selectivity. This has opened up new avenues for the discovery of therapeutics against various diseases.

Recent studies have highlighted the role of 3-bromo-6-chlorophenanthrene in materials science, particularly in the development of organic semiconductors and optoelectronic materials. The halogenated PAHs exhibit enhanced charge transport properties, making them suitable for use in organic field-effect transistors (OFETs) and light-emitting diodes (OLEDs). The electron-withdrawing nature of bromine and chlorine substituents influences the electronic structure of the molecule, thereby tuning its optoelectronic properties. This has led to significant advancements in flexible electronics and energy-efficient lighting technologies.

The synthesis of 3-bromo-6-chlorophenanthrene typically involves halogenation reactions on a phenanthrene precursor. Advanced synthetic methodologies, such as transition-metal-catalyzed halogenation, have been employed to achieve high regioselectivity and yield. These methods not only improve the efficiency of production but also allow for scalable synthesis, which is essential for industrial applications. The growing demand for halogenated PAHs has spurred innovation in synthetic routes, ensuring that researchers have access to high-quality starting materials for their investigations.

The toxicological profile of 3-bromo-6-chlorophenanthrene is another area of active research. While PAHs are known for their potential health risks, the introduction of bromine and chlorine substituents can influence their metabolic pathways and toxicity profiles. Comprehensive toxicological studies are necessary to understand the long-term effects of exposure to this compound. These studies not only inform safer usage practices but also provide insights into the development of safer alternatives with similar chemical properties.

In conclusion, 3-bromo-6-chlorophenanthrene (CAS No. 892550-44-6) represents a fascinating compound with diverse applications across multiple scientific disciplines. Its unique structural features make it a valuable tool in synthetic chemistry, drug discovery, and materials science. As research continues to uncover new possibilities for this compound, it is likely to play an increasingly important role in advancing scientific knowledge and technological innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)